Literature DB >> 18154573

Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.

Pin-Yi Lin1, Chuan-Hang Yu, Jeng-Tzung Wang, Huang-Hsu Chen, Shih-Jung Cheng, Mark Yen-Ping Kuo, Chun-Pin Chiang.   

Abstract

BACKGROUND: Overexpression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) has been found to be significantly associated with the tumor invasion, lymph node metastasis, clinical stage, and prognosis of a variety of human cancers.
METHODS: This study examined the expression of HIF-1 alpha in 57 specimens of oral squamous cell carcinoma (OSCC), 41 specimens of oral epithelial dysplasia (OED, 12 mild, 17 moderate, and 12 severe OED cases), and 14 specimens of normal oral mucosa (NOM) by immunohistochemistry.
RESULTS: We found that the mean nuclear HIF-1 alpha labeling indices (LIs) increased significantly from NOM (9 +/- 6%) through mild OED (25 +/- 18%), moderate OED (41 +/- 27%), and severe OED (42 +/- 22%) to OSCC samples (55 +/- 23%, P < 0.001). A significant correlation was found between the higher mean nuclear HIF-1 alpha LI and OSCCs with larger tumor size (P < 0.001), regional lymph node metastasis (P < 0.001), or more advanced clinical stages (P < 0.001). Only larger tumor size (P = 0.002) and nuclear HIF-1 alpha LI >or= 60% (P = 0.048) were identified as independent unfavorable prognosis factor by multivariate analyses with Cox regression model. Kaplan-Meier curve showed that OSCC patients with a nuclear HIF-1 alpha LI >or= 60% had a significantly poorer cumulative survival than those with a nuclear HIF-1 alpha LI < 60% (log-rank test, P = 0.022).
CONCLUSIONS: We conclude that the expression of HIF-1 alpha is an early event in oral carcinogenesis. The nuclear HIF-1 alpha LI in OSCC samples can predict the progression of OSCCs and the survival of OSCC patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154573     DOI: 10.1111/j.1600-0714.2007.00571.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  29 in total

Review 1.  Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.

Authors:  A W Eckert; M Kappler; J Schubert; H Taubert
Journal:  Oral Maxillofac Surg       Date:  2012-05-17

2.  Dynamic contrast-enhanced MRI of oral squamous cell carcinoma: a preliminary study of the correlations between quantitative parameters and the clinical stage.

Authors:  T Chikui; E Kitamoto; Y Kami; S Kawano; K Kobayashi; T Kamitani; M Obara; K Yoshiura
Journal:  Br J Radiol       Date:  2015-04-23       Impact factor: 3.039

3.  Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.

Authors:  Jun Sato; Yoshimasa Kitagawa; Yutaka Yamazaki; Hironobu Hata; Takuya Asaka; Masaaki Miyakoshi; Shozo Okamoto; Tohru Shiga; Masanobu Shindoh; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-28       Impact factor: 9.236

4.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

5.  Endorsing cellular competitiveness in aberrant epithelium of oral submucous fibrosis progression: neighbourhood analysis of immunohistochemical attributes.

Authors:  Anji Anura; Anees Kazi; Mousumi Pal; Ranjan Rashmi Paul; Sanghamitra Sengupta; Jyotirmoy Chatterjee
Journal:  Histochem Cell Biol       Date:  2018-04-23       Impact factor: 4.304

6.  The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma.

Authors:  Hua Zhou; Ying-Hua Yang; Nada O Binmadi; Patrizia Proia; John R Basile
Journal:  Exp Cell Res       Date:  2012-05-29       Impact factor: 3.905

7.  Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx.

Authors:  F Mera-Menéndez; A Hinojar-Gutiérrez; M Guijarro Rojas; J García de Gregorio; E Mera-Menéndez; J J Sánchez; M Quintanilla; L Cerezo; C Gamallo
Journal:  Clin Transl Oncol       Date:  2012-08-23       Impact factor: 3.405

8.  Hypoxia inducible factor: a potential prognostic biomarker in oral squamous cell carcinoma.

Authors:  Jiang Qian; Xu Wenguang; Wang Zhiyong; Zou Yuntao; Han Wei
Journal:  Tumour Biol       Date:  2016-02-15

9.  An Immunohistochemical Study of HIF-1 Alpha in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.

Authors:  Nikita Rajendrakumar Patel; Leena Jain; Aarti Mahendra Mahajan; Poonam Vilas Hiray; Sandeep S Shinde; Pranjal A Patel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-01-23

10.  Significance of HIF-1α Expression and LOXL-2 Localization in Progression of Oral Squamous Cell Carcinoma.

Authors:  Anshul Bharti; Aadithya B Urs; Priya Kumar
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.